Borsuk E, Mańka R
Department of Embryology, University of Warsaw, Poland.
Gamete Res. 1988 Jul;20(3):365-76. doi: 10.1002/mrd.1120200311.
Our objective was to examine the developmental fate of sperm nuclei in oocytes fertilized under conditions of meiotic arrest. Therefore zona-free metaphase II oocytes and oocyte fragments (nucleate and anucleate) were fertilized in the presence of colcemid. In anucleate oocyte fragments, normal male pronuclei develop. In contrast, in intact oocytes and nucleate fragments sperm nuclei after initial decondensation undergo secondary condensation. This state is maintained as long as the oocytes are treated with colcemid. When the drug is removed 3 h after insemination, the meiotic spindle(s) is reconstructed, the second polar body(ies) is extruded, and a female pronucleus (or micronuclei) forms. At the same time the sperm nucleus decondenses again and transforms into a male pronucleus. In addition oocytes fertilized in the presence of colcemid could not be refertilized. These observations suggest that oocytes and oocyte fragments fertilized in the presence of colcemid undergo activation despite the failure of pronucleus formation. The inhibitory effect of colcemid on the formation of pronuclei is expressed only in the presence of oocyte chromosomes. We suggest that colcemid stabilizes factors responsible for chromosome condensation that are associated with oocyte chromosomes but not factors (whether the same or different) present in the cytoplasm.
我们的目的是研究在减数分裂阻滞条件下受精的卵母细胞中精子核的发育命运。因此,在秋水仙酰胺存在的情况下,对无透明带的中期II卵母细胞和卵母细胞片段(有核和无核)进行受精。在无核卵母细胞片段中,正常的雄原核发育。相反,在完整的卵母细胞和有核片段中,精子核在最初解聚后会经历二次凝聚。只要卵母细胞用秋水仙酰胺处理,这种状态就会维持。授精后3小时去除药物时,减数分裂纺锤体重建,第二极体排出,雌原核(或微核)形成。与此同时,精子核再次解聚并转化为雄原核。此外,在秋水仙酰胺存在下受精的卵母细胞不能再次受精。这些观察结果表明,在秋水仙酰胺存在下受精的卵母细胞和卵母细胞片段尽管原核形成失败,但仍会发生激活。秋水仙酰胺对原核形成的抑制作用仅在卵母细胞染色体存在时才表现出来。我们认为,秋水仙酰胺稳定了与卵母细胞染色体相关的负责染色体凝聚的因子,但不稳定细胞质中存在的因子(无论相同与否)。